hit counter
Cellect Biotechnology Ltd. (APOP) Stock News Sentiment & Price - Sentifly
APOP - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Cellect Biotechnology Ltd. (APOP)

Israel
Biotechnology
NASDAQ
APOP Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
APOP Latest news
GlobeNewsWire
Neutral
Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals
2021-10-15 16:01

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the previously announced strategic merger with privately-held Quoin Pharmaceuticals, Inc., a specialty pharmaceutical company focused on rare and orphan diseases (the “Merger”) and the sale of the Company's subsidiary, Cellect Biotherapeutics Ltd., to EnCellX, Inc., a privately held company based in San Diego, CA (the “Share Transfer”).

Benzinga
Positive
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays
2021-10-04 10:31

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted strong interest and saw shares spike. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Benzinga
Positive
Why Cellect Biotechnology Shares Are Rising Today
2021-09-27 13:01

Cellect Biotechnology Ltd (NASDAQ: APOP) is trading higher Monday after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. Approximately 99% of the votes were in favor of approving the proposal.

Invezz
Positive
Here's why Cellect Biotechnology shares are up 50% on Monday
2021-09-27 10:56

Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning.

GlobeNewsWire
Neutral
Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
2021-09-27 09:10

Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 26, 2021, including the sale of the Company's subsidiary, Cellect Biotherapeutics Ltd, to EnCellX Inc. , a privately held company based in San Diego, CA.

Pulse2
Positive
APOP Stock: Over 70% Increase Pre-Market Explanation
2021-09-03 08:41

The stock price of Cellect Biotechnology Ltd (NASDAQ: APOP) increased by over 70% pre-market. This is why it happened.

Benzinga
Positive
See Why Cellect Biotechnology Stock Is Soaring During Premarket Friday
2021-09-03 08:11

Cellect Biotechnology Ltd (NASDAQ: APOP) announced the first ApoGraft transplantation in a Leukemia patient in a clinical trial in the U.S.  ApoGraft is designed to prevent graft-versus-host disease (GVHD) following bone marrow transplantation.

GlobeNewsWire
Neutral
Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.
2021-09-02 16:20

Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX

GlobeNewsWire
Neutral
Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
2021-08-24 16:16

Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter

Pulse2
Positive
Cellect Biotechnology Shares Increase Over 10% Pre-Market: Why It Happened
2021-08-16 04:45

The shares of Cellect Biotechnology Ltd (NASDAQ: APOP) increased by over 10% pre-market. This is why it happened.

Loading more news...